Estimation of an optimal chemotherapy utilisation rate for lung cancer: An evidence-based benchmark for cancer care

Lung Cancer

Volumn 69, Issue 3, 2010, Pages 307-314

  Jacob, Susannah ^a   Hovey, Elizabeth ^b   Ng, Weng ^a   Vinod, Shalini ^a   Delaney, Geoff P ^a   Barton, Michael B ^a  

^a LIVERPOOL HOSPITAL   (Australia)

^b PRINCE OF WALES HOSPITAL   (Australia)

Author keywords

Chemotherapy utilisation rate; Evidence based clinical guidelines; Lung cancer; Non small cell lung cancer; Optimal chemotherapy utilisation; Small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER CHEMOTHERAPY; EVIDENCE BASED PRACTICE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HUMAN; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; PRACTICE GUIDELINE; PRIORITY JOURNAL; TREATMENT INDICATION;

EID: 77954144946     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2009.11.017     Document Type: Article

References (62)

1. Hotta K., Matsuo K., Ueoka H., Kiura K., Tabata M., Tanimoto M. Role of adjuvant chemotherapy in patients with resected non-small-cell lung cancer: reappraisal with a meta-analysis of randomized controlled trials. J Clin Oncol 2004, 22:3860-3867.
2. Spiro S.G., Rudd R.M., Souhami R.L., Brown J., Fairlamb D.J., Gower N.H., et al. Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life. Thorax 2004, 59:828-836.
3. Agra Y., Pelayo M., Sacristan M., Sacristan A., Serra C., Bonfill X. Chemotherapy versus best supportive care for extensive small cell lung cancer (Review). Cochrane Database Syst Rev 2003, (4). [Art.No:CD001990 1-6-2006].
4. Patel N., Adatia R., Mellemgaard A., Jack R., Moller H. Variation in the use of chemotherapy in lung cancer. Br J Cancer 2007, 96:886-890.
5. Vinod S.K., O'Connell D.L., Simonella L., Delaney G.P., Boyer M., Peters M., et al. Gaps in optimal care for lung cancer. J Thorac Oncol 2008, 3:871-879.
6. Erridge S.C., Murray B., Price A., Ironside J., Little F., Mackean M., et al. Improved treatment and survival for lung cancer patients in South-East Scotland. J Thorac Oncol 2008, 3:491-498.
7. American College of Surgeons National cancer database benchmark reports 2009, [05.05.09]. http://cromwell.facs.org/BMarks/BMPub/Ver9/DxRx/BMPub_DxRx9.cfm.
8. Surveillance Epidemiology and End Results (SEER) Program SEER*RX antineoplastic drug database 2006, National Cancer Institute, DCCPS, Surveillance Research Program, [9-1-2006].
9. National Health and Medical Research Council Clinical practice guidelines for the prevention, diagnosis and management of lung cancer [15-3-2006]. http://www.nhmrc.gov.au/publications.
10. National Comprehensive Cancer Network NCCN Clinical practice guidelines in oncology. Small cell lung cancer. V.2.2009 2009, [28-10-2009]. http://www.nccn.org/professionals/physician_gls/PDF/sclc.pdf.
11. National Cancer Institute PDQ cancer information summaries: treatment of small cell lung cancer 2009, [15-9-0009]. http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/healthprofessional/.
12. BC Cancer Agency Cancer management guidelines for small cell lung cancer [7-6-2006]. http://www.bccancer.bc.ca/.
13. Royal College of Radiologists COIN (Clinical Oncology Information Network) Guidelines on the non-surgical management of lung cancer. Clin Oncol 1999, 11:S1-S53.
14. Cancer Care Ontario The role of combination chemotherapy in the initial management of limited stage small-cell lung cancer. Practice Guideline Report # 7-13-1 2003, [7-6-2006]. http://www.cancercare.on.ca/.
15. National Institute for Clinical Excellence and National Collaborating Centre for Acute Care The diagnosis and treatment of lung cancer. Methods, evidence and guidance 2005, http://www.rcseng.ac.uk/.
16. American College of Chest Physicians Diagnosis and management of lung cancer executive summary: ACCP evidence-based clinical practice guidelines (2nd edition). Chest 2007, 132:1S-19S.
17. American Society of Clinical Oncology Treatment of unresectable non-small cell lung cancer guideline. Update 2003. J Clin Oncol 2004, 22:330-353.
18. National Cancer Institute PDQ Cancer Information summaries: Treatment of non-small cell lung cancer 2009, [15-9-2009]. http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/healthprofessional/.
19. National Comprehensive Cancer Network NCCN clinical practice guidelines in oncology. Non-small cell lung cancer. V.2.2009 2009, [28-10-2009]. http://www.nccn.org/professionals/physician_gls/PDF/nscl.pdf.
20. Cancer Care Ontario Chemotherapy in stage IV (metastatic) non-small cell lung cancer. Practice guideline report # 7-2 2002, [14-3-2006]. http://www.cancercare.on.ca/.
21. Pisters K.M.W., Evans W.K., Azzoli C.G., Kris M.G., Smith C.A., Desch C.E., et al. Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and adjuvant radiation therapy for stages I-IIIA resectable Non-Small-Cell Lung Cancer Guideline. J Clin Oncol 2007, 25:5506-5518.
22. Cancer Care Ontario Postoperative adjuvant chemotherapy, with or without radiotherapy, in completely resected non-small cell lung cancer: a clinical practice guideline. Evidence-based series # 7-1-2 [7-5-2008]. http://www.cancercare.on.ca/pdf/pebc7-1-2s.pdf.
23. BC Cancer Agency Cancer management guidelines for non-small-cell lung cancer 2005, [1-5-2006]. http://www.bccancer.bc.ca/.
24. Rowell N.P., O'Rourke N.P. Concurrent chemoradiotherapy in non-small cell lung cancer. Cochrane Database Syst Rev 2004, [Issue r. Art.No:CD002140.pub2. 2004].
25. Cancer Care Ontario Management of unresected stage III non-small cell lung cancer. Practice guideline report # 7-3 (Version 2.2005) 2005, [14-3-2006]. http://www.cancercare.on.ca/.
26. National Health and Medical Research Council Guide to the development, implementation and evaluation of clinical practice guidelines 1998, [Appendix B, 56].
27. Delaney G., Jacob S., Featherstone C., Barton M.B. The role of radiotherapy in cancer treatment. Estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer 2005, 104:1129-1137.
28. Australian Institute of Health and Welfare (AIHW) Cancer in Australia; an overview, 2006 2007.
29. O'Connell D, Armstrong B, Simonella L, Cancer epidemiology research unit, Cancer Council NSW. Patterns of care in patients with lung cancer. Personal Communication. http://www.nswcc.org.au/editorial.asp%3Fpageid=863.
30. Birim O., Kappetein P., Goorden T., van Klaveren R.J., Bogers A.J. Proper treatment selection may improve survival in patients with clinical early-stage non-small cell lung cancer. Ann Thorac Surg 2005, 80:1021-1027.
31. El-Sherif A., Gooding W.E., Santos R., Pettiford B., Ferson P.F., Fernando H.C., et al. Outcomes of sublobar resection versus lobectomy for Stage I non-small cell lung cancer: a 13-year analysis. Ann Thorac Surg 2006, 82:408-416.
32. Martini N., Bains M.S., Burt M.E., Zakowski M.F., McCormack P., Rusch V.W., et al. Incidence of local recurrence and second primary tumors in resected stage I lung cancer. J Thorac Cardiovasc Surg 1995, 109:120-129.
33. Harpole D.H., Herndon J.E., Young W.G., Wolfe W.G., Sabiston D.C. Stage I nonsmall cell lung cancer. A multivariate analysis of treatment methods and patterns of recurrence. Cancer 1995, 76:787-796.
34. Pasini F., Pelosi G., Valduga F., Durante E., de Manzoni G., Zaninelli M., et al. Late events and clinical prognostic factors in stage I non small cell lung cancer. Lung Cancer 2002, 37:171-177.
35. Park J.H., Lee C.T., Lee H.W., Baek J.H., Zo J.I., Shim Y.M. Postoperative adjuvant chemotherapy for stage I non-small cell lung cancer. Eur J Cardiothor Surg 2005, 27:1086-1091.
36. Pairolero P.C., Williams D.E., Bergstralh E.J., Piehler J.M., Bernatz P.E., Payne W.S. Postsurgical Stage I bronchogenic carcinoma: morbid implications of recurrent disease. Ann Thorac Surg 1984, 38:331-338.
37. Kagami Y., Nishio M., Narimatsu N., Mjoujin M., Sakurai T., Hareyama M., et al. Radiotherapy for loco-regional recurrent tumours after resection of non-small cell lung cancer. Lung Cancer 1998, 20:31-35.
38. Jeremic B., Shibamoto Y., Acimovic L., Milisavljevic S. Initial versus delayed accelerated hyperfractionated radiation therapy and concurrent chemotherapy in small cell lung cancer: a randomised study. J Clin Oncol 1997, 15:893-900.
39. Zhang H.X., Yin W.B., Zhang L.J., Yang Z.Y., Zhang Z.X., Wang M., et al. Curative radiotherapy of early operable non-small cell lung cancer. Radiother Oncol 1989, 14:89-94.
40. de Rijke J.M., Schouten L.J., ten Velde G.P.M., Wanders S.L., Bollen E.C., Lalisang R.I., et al. Influence of age, comorbidity and performance status on the choice of treatment for patients with non-small cell lung cancer; results of a population-based study. Lung Cancer 2004, 46:233-245.
41. Jeremic B., Shibamoto Y., Acimovic L., Milisavljevic S. Hyperfractionated radiotherapy alone for clinical stage I nonsmall cell lung cancer. Int J Radiat Oncol Biol Phys 1997, 38:521-525.
42. Sibley G.S., Jamieson T.A., Marks L.B., Anscher M.S., Prosnitz L.R. Radiotherapy alone for medically inoperable stage I non-small cell lung cancer: the Duke experience. Int J Radiat Oncol Biol Phys 1998, 40:149-154.
43. Krol A.D.G., Aussems P., Noordijk E.M., Hermans J., Leer J.W. Local irradiation alone for peripheral stage I lung cancer: could we omit the elective regional nodal irradiation?. Int J Radiat Oncol Biol Phys 1996, 34:297-302.
44. Hayakawa K., Mitsuhashi N., Saito Y., Nakayama Y., Furuta M., Sakurai H., et al. Limited field irradiation for medically inoperable patients with peripheral stage I non-small cell lung cancer. Lung Cancer 1999, 26:137-142.
45. Fry W.A., Menck H.R., Winchester D.P. The national cancer database report on lung cancer. Cancer 1996, 77:1947-1955.
46. Richardson G.E., Thursfield V.J., Giles G.G. Reported management of lung cancer in Victoria in 1993: comparison with best practice. MJA 2000, 172:321-324.
47. Vinod S.K., Delaney G.P., Bauman A., Barton M.B. Lung cancer patterns of care in south western Sydney, Australia. Thorax 2003, 58:690-694.
48. Mahmud S.M., Reilly M., Comber H. Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study. Lung Cancer 2003, 41:57-64.
49. Gregor A., Thomson C.S., Brewster D.H., Stroner P.L., Davidson J., Ferguson R.J., et al. Management and survival on lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax 2001, 56:212-217.
50. Pepe C., Hasan B., Winton T.L., Seymour L., Graham B., Livingstone R.B., et al. Adjuvant vinorelbine and cisplatin in elderly patients: National Cancer Institute of Canada and Intergroup Study JBR.10. J Clin Oncol 2007, 25:1553-1561.
51. Earle C.C., Tsai J.S., Gelber R.D., Weinstein M.C., Neumann P.J., Weeks J.C. Effectiveness of chemotherapy for advanced lung cancer in the elderly: instrumental variable and propensity analysis. J Clin Oncol 2001, 19:1064-1070.
52. Langer C.J., Hsu C., Curran W.J. Elderly patients with locally advanced non-small cell lung cancer benefit from combined modality therapy: secondary analysis of Radiation Therapy Oncology Group (RTOG) 94-10. Proc Am Soc Clin Oncol 2002, 21(299a). [abstr 1193.].
53. Chen Y.M., Perng R.P., Shih J.F., Tsai C.M., Whang-Peng J. Chemotherapy for non-small cell lung cancer in elderly patients. Chest 2005, 128:132-139.
54. Janssen-Heijnen M.L., Schipper R.M., Razenberg P.P.A., Crommelin M.A., Coebergh J.W. Prevalence of co-morbidity in lung cancer patients and its relationship with treatment: a population-based study. Lung Cancer 1998, 21:105-113.
55. Piccirillo J.F. Importance of comorbidity in head and neck cancer. Laryngoscope 2000, 110:593-602.
56. de Ruysscher D., Botterweck A., Dirx M., Pijls-Johannesma M., Wanders R., Hochstenbag M., et al. Eligibility for concurrent chemotherapy and radiotherapy for locally advanced lung cancer patients: a prospective, population-based study. Ann Oncol 2009, 20:98-102.
57. Janssen-Heijnen M.L., Smulders S., Lemmens V.E.P.P., Smeenk F.W., van Geffen H.J., Coebergh J.W. Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancer. Thorax 2004, 59:602-607.
58. Shepherd F.A., Amdemichael E., Evans W.K., Chalvardjian P., Hogg-Johnson S., Coates R., et al. Treatment of small-cell lung cancer in the elderly. J Am Geriatr Soc 1994, 42:64-70.
59. Dajczman E., Fu L.Y., Small D., Wallkove N., Kreisman H. Treatment of small cell lung carcinoma in the elderly. Cancer 1996, 77:2032-2038.
60. Jansen S.J.T., Otten W., Stiggelbout A.M. Review of determinants of patients' preferences for adjuvant therapy in cancer. J Clin Oncol 2004, 22:3181-3190.
61. Silvestri G., Pritchard R., Welch H.G. Preferences for chemotherapy in patients with advanced non-small cell lung cancer: descriptive study based on scripted interviews. BMJ 1998, 317:771-775.
62. Hirose T., Horichi N., Ohmori T., Kusumoto S., Sugiyama T., Shirai T., et al. Patient preferences in chemotherapy for advanced non-small cell lung cancer. Int Med 2005, 44:107-113.